Pfizer Takes FDA Endorsement for Humira Biosimilar
The FDA has established adalimumab-afzb (Abrilada), Pfizer’s tumor necrosis circumstance biosimilar to Humira (AbbVie) for the therapy of patients with rheumatoid arthritis, juvenile idiopathic arthritis,…